BioMatt focuses on JMI’s investments in software and healthcare IT businesses. He currently oversees the investments or serves on the boards of Axonify, CipherHealth, Healthx, PointClickCare, and Workfront. Prior to joining JMI in 2006, Matt was an analyst in the technology investment banking group at Thomas Weisel Partners and a research associate at Thompson, Siegel & Walmsley. Matt is a CFA charter holder.
Education